Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis.
OBJECTIVE
Bloodstream infections related to use of catheters, particularly central-line catheters, are an important cause of patient morbidity, mortality, and increased health care costs. This study evaluated the efficacy of skin disinfection with chlorhexidine gluconate compared with povidone-iodine solution in preventing catheter-related bloodstream infection.


METHODS
Multiple computerized databases (1966 to 2001), reference lists of identified articles, and queries of principal investigators and antiseptic manufacturers.


METHODS
Randomized, controlled trials comparing chlorhexidine gluconate with povidone-iodine solutions for catheter-site care.


METHODS
Using a standardized form, two reviewers abstracted data on study design, patient population, intervention, and incidence of catheter-related bloodstream infection from all included studies.


RESULTS
Eight studies involving a total of 4143 catheters met the inclusion criteria. All studies were conducted in a hospital setting, and various catheter types were used. The summary risk ratio for catheter-related bloodstream infection was 0.49 (95% CI, 0.28 to 0.88) in patients whose catheter sites were disinfected with chlorhexidine gluconate instead of povidone-iodine. Among patients with a central vascular catheter, chlorhexidine gluconate reduced the risk for catheter-related bloodstream infection by 49% (risk ratio, 0.51 [CI, 0.27 to 0.97]).


CONCLUSIONS
These results suggest that incidence of bloodstream infections is significantly reduced in patients with central vascular lines who receive chlorhexidine gluconate versus povidone-iodine for insertion-site skin disinfection. Use of chlorhexidine gluconate is a simple and effective means of reducing vascular catheter-related infections.
Chaiyakunapruk
Nathorn
N
Department of Pharmacy Practice, School of Pharmacy, Naresuan University, Pitsanuloak 65000, Thailand.
Veenstra
David L
DL
Lipsky
Benjamin A
BA
Saint
Sanjay
S
D000368:Aged; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002710:Chlorhexidine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004202:Disinfectants / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011206:Povidone-Iodine / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012680:Sensitivity and Specificity; D018805:Sepsis / Q000517:prevention & control*; D012996:Solutions
D000891:Anti-Infective Agents, Local; D004202:Disinfectants; D012996:Solutions; D011206:Povidone-Iodine; C010882:chlorhexidine gluconate; D002710:Chlorhexidine